Tirzepatide (Zepbound) is a dual GLP-1 and GIP agonist that helps with weight loss by targeting hunger, fat storage, and metabolism. Clinical trials show up to 22.5% weight loss, outperforming other drugs like semaglutide.
The low-GI diet helps control blood sugar and reduce cravings, making it easier to manage weight over time. It doesn't guarantee fast weight loss, but it supports long-term health by focusing on whole, unprocessed foods.
